Physician profile
John Sanders
NPI 1740444173
$245.10
in general payments reported to CMS, 2019-2025
12 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.89 · 2022: $18.52 · 2023: $13.30 · 2024: $73.18 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.89 | 2019 | |
| Baxter Healthcare | $29.34 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Biomerieux INC | $28.00 | 2024 | Biofire Spotfire Respiratory (R) Panel |
| Pfizer INC. | $20.47 | 2025 | |
| Astellas Pharma US INC | $19.98 | 2025 | Veozah |
| Globus Medical, INC. | $19.45 | 2025 | Senza |
| Organon LLC | $18.52 | 2022 | |
| Mckesson Medical-Surgical, INC. | $15.84 | 2024 | |
| Exact Sciences Corporation | $15.80 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $14.97 | 2025 | Zepbound, Mounjaro |
| Abbvie INC. | $14.54 | 2025 | |
| Boston Scientific Corporation | $13.30 | 2023 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.